Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYabalak, A.
dc.contributor.authorAltunrende, B.
dc.contributor.authorAkman Demir, G.
dc.date.accessioned2022-01-29T16:52:25Z
dc.date.available2022-01-29T16:52:25Z
dc.date.issued2021
dc.identifier.issn13000667
dc.identifier.urihttps://doi.org/10.29399/npa.24928
dc.identifier.urihttp://hdl.handle.net/11446/4466
dc.description.abstractIntroduction: There are few studies on cognitive impairment in neuromyelitis optica (NMO). The purpose of this study is to assess the factors that may be related with the frequency and level of cognitive impairment in Turkish NMO patients. Methods: 22 patients with the diagnosis of NMO are evaluated retrospectively. Cognitive function was evaluated with Brief Repeatable Battery of Neuropsychological tests (BRB-N), Beck Depression Inventory (BDI) and Addenbrooke Cognitive Evaluation (ACE-R). The groups with and without cognitive impairment were compared according to age, sex, level of education, pathologic findings on cranial MRI, NMO Ig existence and EDSS score. The relation of the clinical, radiological and demographic values and patients’ depression level was evaluated. The specificity and sensitivity of ACE-R test on detecting cognitive impairment were assessed through ACE-R test results. Results: The mean age of the patients was 42.8±10.9.45.5% (n=10) of the patients had cognitive impairment and 50% (n=11) had depression. The group with cognitive impairment had significantly older age, lower educational status, higher EDSS and BDI scores (p<0.05). The mostly affected cognitive domains were memory impairment, attention and processing dysfunction. When the specificity and sensitivity of ACE-R test on NMO patients were evaluated, diagnostic level of the test was found to be statistically good since it could detect cognitive impairment with a sensitivity of 88% and specificity of 75% on a cut off level of 82.5. Conclusion: In our study, cognitive impairment and depression were detected in approximately half of the patients with BRB-N and BDI tests. It can be concluded that ACE-R test can be used to detect cognitive impairment in NMO patients. Since cognitive impairment and depression are frequent in NMO patients, it is important to assess the patients’ cognitive functions and arrange the treatments to improve their quality of life, . © 2021, Turkish Neuropsychiatric Society. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherTurkish Neuropsychiatric Societyen_US
dc.identifier.doi10.29399/npa.24928
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectACE-R; BRB-N; Cognitive impairment; Depression; Neuromyelitis opticaen_US
dc.subjectAddenbrooke Cognitive Evaluationen_US
dc.subjectadulten_US
dc.subjectageen_US
dc.subjectageden_US
dc.subjectantiphospholipid syndromeen_US
dc.subjectArticleen_US
dc.subjectattentionen_US
dc.subjectattention disturbanceen_US
dc.subjectautoimmune thyroiditisen_US
dc.subjectBeck Depression Inventoryen_US
dc.subjectBrief Repeatable Battery of Neuropsychological testen_US
dc.subjectclinical articleen_US
dc.subjectcognitive defecten_US
dc.subjectcontrolled studyen_US
dc.subjectdepressionen_US
dc.subjectdiagnostic test accuracy studyen_US
dc.subjectdisease durationen_US
dc.subjectdivorced personen_US
dc.subjecteducational statusen_US
dc.subjectExpanded Disability Status Scaleen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectmaleen_US
dc.subjectmarried personen_US
dc.subjectmemory disorderen_US
dc.subjectMini Mental State Examinationen_US
dc.subjectmyasthenia gravisen_US
dc.subjectmyelooptic neuropathyen_US
dc.subjectneuropsychological testen_US
dc.subjectnuclear magnetic resonance imagingen_US
dc.subjectpaced auditory serial addition testen_US
dc.subjectquality of lifeen_US
dc.subjectreceiver operating characteristicen_US
dc.subjectretrospective studyen_US
dc.subjectSelective Reminding Testen_US
dc.subjectsensitivity and specificityen_US
dc.subjectsex differenceen_US
dc.subjectsingle (marital status)en_US
dc.subjectSjoegren syndromeen_US
dc.subjectspatial Recall Testen_US
dc.subjectsymbol digit modalities testen_US
dc.subjectWord List Generation Testen_US
dc.titleCognitive impairment in neuromyelitis opticaen_US
dc.title.alternativeNöromiyelitis Optika’da Kognitif Bozukluken_US
dc.typearticleen_US
dc.relation.journalNoropsikiyatri Arsivien_US
dc.departmentDBÜen_US
dc.identifier.issue3en_US
dc.identifier.volume58en_US
dc.identifier.startpage200en_US
dc.identifier.endpage205en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempYabalak, A., Department of Neurology, VM Medical Park Pendik Hospital, İstanbul, Turkey; Altunrende, B., Department of Neurology, Demiroğlu Bilim University, Faculty of Medicine, İstanbul, Turkey; Akman Demir, G., Department of Neurology, Demiroğlu Bilim University, Faculty of Medicine, İstanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster